Vis enkel innførsel

dc.contributor.authorWestern, Benedikte
dc.contributor.authorDemmelmaier, Ingrid
dc.contributor.authorVistad, Ingvild
dc.contributor.authorHansen, Bjørge Hermann
dc.contributor.authorStenling, Andreas
dc.contributor.authorHenriksen, Hege
dc.contributor.authorNordin, Karin
dc.contributor.authorBlomhoff, Rune
dc.contributor.authorBerntsen, Sveinung
dc.date.accessioned2023-09-14T12:19:41Z
dc.date.available2023-09-14T12:19:41Z
dc.date.created2023-05-22T09:44:59Z
dc.date.issued2023
dc.identifier.issn1932-6203
dc.identifier.urihttps://hdl.handle.net/11250/3089485
dc.description.abstractBackground Physical activity (PA) monitoring is applied in a growing number of studies within cancer research. However, no consensus exists on how many days PA should be monitored to obtain reliable estimates in the cancer population. The objective of the present study was to determine the minimum number of monitoring days required for reliable estimates of different PA intensities in cancer survivors when using a six-days protocol. Furthermore, reliability of monitoring days was assessed stratified on sex, age, cancer type, weight status, and educational level. Methods Data was obtained from two studies where PA was monitored for seven days using the SenseWear Armband Mini in a total of 984 cancer survivors diagnosed with breast, colorectal or prostate cancer. Participants with ≥22 hours monitor wear-time for six days were included in the reliability analysis (n = 736). The intra-class correlation coefficient (ICC) and the Spearman Brown prophecy formula were used to assess the reliability of different number of monitoring days. Results For time in light PA, two monitoring days resulted in reliable estimates (ICC >0.80). Participants with BMI ≥25, low-medium education, colorectal cancer, or age ≥60 years required one additional monitoring day. For moderate and moderate-to-vigorous PA, three monitoring days yielded reliable estimates. Participants with BMI ≥25 or breast cancer required one additional monitoring day. Vigorous PA showed the largest within subject variations and reliable estimates were not obtained for the sample as a whole. However, reliable estimates were obtained for breast cancer survivors (4 days), females, BMI ≥30, and age <60 years (6 days). Conclusion Shorter monitoring periods may provide reliable estimates of PA levels in cancer survivors when monitored continuously with a wearable device. This could potentially lower the participant burden and allow for less exclusion of participants not adhering to longer protocols.en_US
dc.language.isoengen_US
dc.publisherPLOSen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleHow many days of continuous physical activity monitoring reliably represent time in different intensities in cancer survivorsen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2023 The Author(s)en_US
dc.source.articlenumbere0284881en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.1371/journal.pone.0284881
dc.identifier.cristin2148357
dc.source.journalPLOS ONEen_US
dc.identifier.citationPLOS ONE. 2023, 18 (4), e0284881.en_US
dc.source.volume18en_US
dc.source.issue4en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal